Skip to main navigation Skip to search Skip to main content

Is the Pathological Chemotherapy Response Score (CRS) a Surrogate for Survival? - An International Multicentre Collaborative Analysis of High-Grade Serous Tubo-Ovarian Carcinoma Treated with Neoadjuvant Chemotherapy and Interval Debulking Surgery.

Research output: Contribution to conferencePosterpeer-review

Original languageEnglish
Publication statusPublished - 14 Sept 2018
EventInternational Gynecological Cancer Society - Kyoto, Japan
Duration: 14 Sept 201816 Sept 2018

Conference

ConferenceInternational Gynecological Cancer Society
Abbreviated titleIGCS
Country/TerritoryJapan
CityKyoto
Period14/09/201816/09/2018

Cite this